Project Details
Description
A Randomized, Open Label, Multi-Center, Phase 3 Efficacy Study of Sub-Q Abatacept in Preventing Extension of Oligoarticular JIA (Limit-JIA)
| Status | Active |
|---|---|
| Effective start/end date | 10/9/19 → 3/31/25 |
Funding
- DUKE UNIVERSITY
- PATIENT-CENTERED OUTCOMES RESEARCH INST.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.